TTS Call for Nominations

We are now accepting nominations for three (3) Officer positions and nine (9) Councilors-at-large positions representing the Regions.


Officer Positions:

  • President-Elect
  • Secretary
  • Treasurer

TTS Regional Councilors:

  • Asia (3 - one per sub-region)
  • Latin America (3)
  • North America (2)
  • Oceania (1)

ISODP 2023 Recordings are now available!

175 Presentations are now available for TTS and ISODP Members to view.

Celebrating Excellence - Spotlight on TTS Members

TTS would like to congratulate our fellow members who were recently recognized by their peers at the IPITA-IXA-CTRMS 2023 Congress. Members have access to the video presentations!

Chung-Gyu Park

IXA - Keith Reemtsma Lecture

Richard N. Pierson III

IXA - Honorary Lecture

Linda Scobie

IXA - Agnès Azimzadeh Award

Muhammad Mohiuddin

IXA - Carl-Gustav Groth Xeno Prize

Joe Ladowski

IXA - David K.C. Cooper Young Investigator Award

Bernhard J. Hering

IPITA - Paul E. Lacy Memorial Lecture

Stephen T. Bartlett

IPITA - Richard C. Lillehei Memorial Lecture

Andrea Peloso

IPITA - Derek Gray Distinguished Traveling Scholarship Award

Ibrahim Fathi

IPITA - Derek Gray Distinguished Traveling Scholarship Award

TTS Seeking a New Editor-in-Chief for Transplantation and Transplantation Direct

Jeremy Chapman

Transplantation Journals
Professor Jeremy R. Chapman, a dedicated leader at the helm of Transplantation and Transplantation Direct, has announced his intention to retire from the role of Editor-in-Chief of The Transplantation Society’s journals at the close of 2024.
Prof. Chapman's profound commitment to The Transplantation Society (TTS) spans over a quarter-century, during which he has undertaken multiple pivotal roles, from Councilor to President. Notably, his tenure as Editor-in-Chief over the past decade has yielded a remarkable transformation in our publications. Under his steadfast guidance, we witnessed the inception of our open-access journal, Transplantation Direct, significant enhancements in submission procedures, expedited review times and new innovations that have resulted in a significant uptrend in our impact factor and readership. Prof. Chapman's unwavering dedication extended to assembling an exceptional team, whose collaborative efforts have been instrumental in achieving these milestones. His impending retirement will close an exceptional chapter in TTS history.
As we embark on a new chapter, we are inviting applications for the position of Editor-in-Chief, which will commence on July 1, 2024, with a six-month transitional period leading to full responsibility for the journals as of January 1, 2025. The initial term of service is set for five years, with the potential for renewal. The deadline for submissions is December 31, 2023. For a comprehensive overview of this opportunity, please click on the link below. We look forward to welcoming the next visionary leader who will continue the legacy of excellence in our publications.

Read the full description
Transplantation, Transplantation Direct

The Transplantation Society (TTS) ( is an inclusive, innovative and future-focused society, where both staff and members are thought leaders in advancing knowledge in the service of the field of Transplantation. We are seeking an incumbent who will provide vision and leadership that will enhance our position as a leading Society in the field of Transplantation Sciences through our two journals:

Transplantation ( and
Transplantation Direct (

Appointment is on the joint establishment of TTS and Wolters Kluwer Health, on the conditions of service of TTS.

Reporting through the President and Council of The Transplantation Society.

  • Overall strategic leadership and operational management of the Executive Editorial team of Transplantation and the Editor of Transplantation Direct on behalf of both TTS and Wolters Kluwer health, giving expression to its vision of remaining world-class leading journals in the field.
  • Fostering an inclusive and collegial environment that encourages a high level of performance, communication and teamwork.
  • Overall responsibility for a strong editorial vision regarding research and innovation, which includes leading, mentoring and participating in TTS strategic priority areas, and fostering collaboration with TTS projects including professional meetings, workshops, and other appropriate forums.
  • Providing strong editorial vision and content to increase impact, size, reach and visibility and financial performance of the Society’s journals.
  • Together with the WKH and TTS, developing strategies to advance high‐quality content in both print and online formats, as evidenced by metrics such as impact factors, citations, web traffic, and readership numbers.
  • Ensuring proper and efficient manuscript flow to guarantee on‐time publication, soliciting content and/or editorials as appropriate.
  • Protecting the highest standards of scientific and ethical integrity in published material.
  • Staying informed of publications in the field of transplantation, clinical and basic research designs, basic concepts of statistics, and ethics of research and publishing.
  • Understanding the guidelines of the International Committee of Medical Journal Editors and the Committee on Publication Ethics.
  • Selecting and leading a high‐performing international editorial board, review team and guest editors whose knowledge base represents the topics covered in the editorial mission of the journals.
  • Responsible for making final decisions on all submitted manuscripts.
  • Respecting the integral nature of and close cooperation between Transplantation and Transplantation Direct while fostering the success and growth of both journals.

Job Requirements

  • A relevant postgraduate degree in the field of transplantation, or relevant research.
  • Experience in conducting research as well as research supervision, scientific manuscript publication and editing.
  • Proven international recognition as a specialist in the field of Transplantation, with sophistication and breadth of understanding of the scientific, clinical, ethical and social aspects of transplantation.
  • TTS membership
  • The Editor-in-Chief shall set his/her own working hours; however, it is expected to devote an estimated 20 hours/ week, travel to TTS council meetings as required and attend the TTS biannual congress.


  • A leadership style that is inclusionary, develops diversity and is respectful of differing opinions.
  • Experience in human resource as well as financial management.
  • Demonstrates a strong understanding of contemporary publishing issues.
  • A track record of capacity building across different regions of the world.
  • A track record of dealing with complex ethical issues.

Commencement of Duty

  • There will be a six month overlap with the current Editor in Chief between 1 July 2024 and 31 December 2024.
  • Full responsibility for the journals will commence on 1 January 2025.
  • The initial period of service is for a 5-year term. The term may be renewed for a successive term of three (3) years by mutual agreement.

Closing Date and Admission Process

  • Interested applicants are requested to submit an application to The Transplantation Society’s Executive Director at by December 31, 2023 including:
    • a curriculum vitae
    • five academic publications as senior/corresponding author
    • a letter of support from the Dean or Department Chair/Head of the person’s academic or clinical affiliation
    • a detailed vision statement of not more than 3000 words describing the person’s alignment to the role and to TTS, including a vision for the future for both the journals: Transplantation and Transplantation Direct

Further Enquiries

Background Information

Transplantation is an international, peer‐reviewed journal, and has been the world's most frequently cited journal in the field of transplantation for 60 years. Transplantation is consistently ranked among the top impact factor journals in Transplantation, Surgery and Immunology, with a current 1 year Impact Factor of 6.2.

Transplantation Direct, was founded in 2015 as the open access online sibling journal to Transplantation, and has developed a growing role in the publication of papers in the field. It was provided an Impact Factor for 2022 and has a current 1 year Impact Factor score of 2.3 which is above many well established journals in the field.

Both journals publish original scientific research, reviews, and opinion pieces in all fields of transplantation covering clinical, basic and translational science, to provide the international community with information on significant contributions to the advancement of medical, surgical and immunological science impacting transplant practice, health system and patient outcomes.

The copyright for Transplantation is owned by Wolters Kluwer Health (WKH), and is the official journal of The Transplantation Society. Transplantation Direct is jointly owned by Wolters Kluwer Health and The Transplantation Society.

Currently, the editorial team consists of 6 Executive Editors, and approximately 130 Deputy and Associate Editors and a Social Media Editor. Editorial management services are provided by KnowledgeWorks Global Ltd. (KGL). The team of reviewers exceeds 2,000. The Editor-in-Chief is fully responsible for the editorial services needed for the publication of twelve (12) Transplantation monthly issues per year in accordance with an agreed upon production schedule while providing linkage to and oversight of Transplantation Direct.

The Transplantation Society (
Transplantation (
Transplantation Direct (

News Spotlight

India’s first child liver transplant recipient in 1998 is now a doctor

New Delhi: On November 15, 1998, Sanjay Kandasamy was only 20-months-old when a team of doctors from Delhi’s Indraprastha Apollo Hospital performed a life-saving liver transplant on him, making him the first paediatric liver transplantee in the country. Twenty-five years since, Sanjay is now a doctor himself!

Steve Paraskevas receives CST 2023 Excellence in Leadership Award

Jeffrey Schiff (Past President, CST), Steve Paraskevas, Jean Tchervenkov, Jag Gill, (President, CST)
Steve Paraskevas was recognized as the 2023 recipient of the Excellence in Leadership Award from the Canadian Society of Transplantation (CST).

In Case You Missed It...Recent Recordings

Joint Congress Recordings are now available!

IPITA, IXA, and CTRMS thanks the over 600 attendees from 30 countries who attended and supported the 2023 Joint Congress in San Diego, California on October 26-29, 2023. Attendees were offered an outstanding and innovative 4-day program, with leading experts and opinion leaders, highlighting breakthroughs in science, research and technology as well as various opportunities to network with peers, mentors and industry.

Transplantation Journal Highlights

Transplantation - Highlighted Tweets

What’s New: Updates on Cytomegalovirus in Solid Organ Transplantation
Cytomegalovirus (CMV) is one of the most common infections occurring after solid organ transplantation. This high burden of disease, which incurs sizeable morbidity, may be worsening with the proportion of high-risk D+/R− solid organ transplantation recipients increasing in some regions globally. Cohort studies continue to support either universal prophylaxis or preemptive therapy as effective prevention strategies.
TMA in Kidney Transplantation
Thrombotic microangiopathy (TMA) is a rare and devastating complication of kidney transplantation, which often leads to graft failure. Posttransplant TMA (PT-TMA) may occur either de novo or as a recurrence of the disease. De novo TMA can be triggered by immunosuppressant drugs, antibody-mediated rejection, viral infections, and ischemia/reperfusion injury in patients with no evidence of the disease before transplantation.

Transplantation Direct - Highlighted Tweets

Transplantation Direct - November Issue
Delayed Graft Function Among Kidney Transplant Recipients Is Associated With an Increased Risk of Urinary Tract Infection and BK Viremia
Delayed graft function (DGF) among deceased donor kidney transplant recipients (DDKTRs) is a well-known risk factor for allograft rejection, decreased graft survival, and increased cost. Although DGF is associated with an increased risk of rejection, it is unclear whether it also increases the risk of infection.

In the News 



Staff Directory


The Transplantation Society
International Headquarters
740 Notre-Dame Ouest
Suite 1245
Montréal, QC, H3C 3X6